Eph-modulated cell morphology, adhesion and motility in carcinogenesis

IUBMB Life

Volumn 57, Issue 6, 2005, Pages 421-431

  Wimmer Kleikamp, Sabine H ^a   Lackmann, Martin ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adhesion; Eph; Invasion; Metastasis; Motility; Neo angiogenesis; RTK

Indexed keywords

EPHRIN; EPHRIN RECEPTOR; INTEGRIN; PROTEIN TYROSINE KINASE;

ANGIOGENESIS; BRAIN CANCER; BREAST CANCER; CANCER THERAPY; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; COLON CANCER; HUMAN; LYMPHATIC SYSTEM TUMOR; MELANOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN STRUCTURE; PROTO ONCOGENE; REVIEW;

ADULT; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL MOVEMENT; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; EPHRINS; HUMANS; NEOPLASMS; RECEPTORS, EPH FAMILY; SYNTENY; UP-REGULATION;

EID: 23044435769     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540500138337     Document Type: Review

References (87)

1. Kullander, K., and Klein, R. (2002) Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3, 475-486.
2. Poliakov, A., Cotrina, M., and Wilkinson, D. G. (2004) Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev. Cell. 7, 465-480.
3. Drescher, U. (2002) Eph family functions from an evolutionary perspective. Curr. Opin. Genet. Dev. 12, 397-402.
4. Himanen, J. P., Chumley, M. J., Lackmann, M., Li, C., Barton, W. A., Jeffrey, P. D., Vearing, C., Geleick, D., Feldheim, D. A., Boyd, A. W., Henkemeyer, M., and Nikolov, D. B. (2004) Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signalling. Nat. Neurosci. 7, 501-509.
5. Adams, R. H. (2003) Molecular control of arterial-venous blood vessel identity. J. Anat. 202, 105-112.
6. Sharfe, N., Freywald, A., Toro, A., and Roifman, C. M. (2003) Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J. Immunol. 170, 6024-6032.
7. Yu, G., Luo, H., Wu, Y., and Wu, J. (2004) EphrinB1 is essential in T-cell-T-cell co-operation during T-cell activation. J. Biol. Chem. 279, 55531-9.
8. Reber, M., Burrola, P., and Lemke, G. (2004) A relative signalling model for the formation of a topographic neural map. Nature 431, 847-853.
9. Gerlai, R. (2001) Eph receptors and neural plasticity. Nat. Rev. Neurosci. 2, 205-209.
10. Nakamoto, M., and Bergemann, A. D. (2002) Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc. Res. Tech. 59, 58-67.
11. Hafner, C., Schmitz, G., Meyer, S., Bataille, F., Hau, P., Langmann, T., Dietmaier, W., Landthaler, M., and Vogt, T. (2004) Differential gene expression of Eph receptors and ephrins in various benign human tissues and cancers. Clin. Chem. 50, 490-499.
12. Brantley-Sieders, D., Parker, M., and Chen, J. (2004) Eph receptor tyrosine kinases in tumor and tumor microenvironment. Curr. Pharm. Des. 10, 3431-3442.
13. Dodelet, V. C., and Pasquale, E. B. (2000) Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19, 5614-5619.
14. Varelias, A., Koblar, S. A., Cowled, P. A., Carter, C. D., and Clayer, M. (2002) Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. Cancer 95, 862-869.
15. Fox, B. P. and Kandpal, R. P. (2004) Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem. Biophys. Res. Commun. 318, 882-892.
16. Maru, Y., Hirai, H., and Takaku, F. (1990) Overexpression confers an oncogenic potential upon the eph gene. Oncogene 5, 445-447.
17. Miao, H., Wei, B. R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., and Wang, B. (2001) Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell. Biol. 3, 527-530.
18. Carles-Kinch, K., Kilpatrick, K. E., Stewart, J. C., and Kinch, M. S. (2002) Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res. 62, 2840-2847.
19. Gale, N. W., Baluk, P., Pan, L., Kwan, M., Holash, J., DeChiara, T. M., McDonald, D. M., and Yancopoulos, G. D. (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev. Biol. 230, 151-160.
20. Santiago, A. and Erickson, C. A. (2002) Ephrin-B ligands play a dual role in the control of neural crest cell migration. Development 129, 3621-3632.
21. Easty, D. J. and Bennett, D. C. (2000) Protein tyrosine kinases in malignant melanoma. Melanoma Res. 10, 401-411.
22. Chiari, R., Hames, G., Stroobant, V., Texier, C., Maillere, B., Boon, T., and Coulie, P. G. (2000) Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res. 60, 4855-4863.
23. Vogt, T., Stolz, W., Welsh, J., Jung, B., Kerbel, R. S., Kobayashi, H., Landthaler, M., and McClelland, M. (1998) Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin. Cancer Res. 4, 791-797.
24. Hendrix, M. J., Seftor, E. A., Kirschmann, D. A., Quaranta, V., and Seftor, R. E. (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann. NY Acad. Sci. 995, 151-161.
25. Walker-Daniels, J., Hess, A. R., Hendrix, M. J., and Kinch, M. S. (2003) Differential regulation of EphA2 in normal and malignant cells. Am. J. Pathol. 162, 1037-1042.
26. Andres, A. C., Reid, H. H., Zurcher, G., Blaschke, R. J., Albrecht, D., and Ziemiecki, A. (1994) Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis. Oncogene 9, 1461-1467.
27. Wu, Q., Suo, Z., Risberg, B., Karlsson, M. G., Villman, K., and Nesland, J. M. (2004) Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol. Oncol. Res. 10, 26-33.
28. Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., and Clevers, H. (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111, 251-263.
29. Liu, W., Ahmad, S. A., Jung, Y. D., Reinmuth, N., Fan, F., Bucana, C. D., and Ellis, L. M. (2002) Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer 94, 934-939.
30. Saito, T., Masuda, N., Miyazaki, T., Kanoh, K., Suzuki, H., Shimura, T., Asao, T., and Kuwano, H. (2004) Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Oncol. Rep. 11, 605-611.
31. Nakada, M., Niska, J. A., Miyamori, H., McDonough, W. S., Wu, J., Sato, H., and Berens, M. E. (2004) The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res. 64, 3179-3185.
32. Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., and Pasquale, E. B. (2000) The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19, 6043-6052.
33. Dobrzanski, P., Hunter, K., Jones-Bolin, S., Chang, H., Robinson, C., Pritchard, S., Zhao, H., and Ruggeri, B. (2004) Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 64, 910-919.
34. Dottori, M., Down, M., Huttmann, A., Fitzpatrick, D. R., and Boyd, A. W. (1999) Cloning and characterization of EphA3 (Hek) gene promoter: Blood DNA methylation regulates expression in hematopoietic tumor cells. 94, 2477-2486.
35. Sharfe, N., Freywald, A., Toro, A., Dadi, H., and Roifman, C. (2002) Ephrin stimulation modulates T cell chemotaxis. Eur. J. Immunol. 32, 3745-3755.
36. Smith, L. M., Walsh, P. T., Rudiger, T., Cotter, T. G., Mc Carthy, T. V., Marx, A., and O'Connor, R. (2004) EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion. Exp. Cell Res. 292, 295-303.
37. Cowan, C. A., and Henkemeyer, M. (2002) Ephrins in reverse, park and drive. Trends Cell Biol. 12, 339-346.
38. Gauthier, L. R., and Robbins, S. M. (2003) Ephrin signalling: One raft to rule them all? One raft to sort them? One raft to spread their call and in signalling bind them? Life Sci. 74, 207-216.
39. Wimmer-Kleikamp, S. H., Janes, P. W., Squire, A., Bastiaens, P. I., and Lackmann, M. (2004) Recruitment of Eph receptors into signalling clusters does not require ephrin contact. J. Cell Biol. 164, 661-666.
40. Mellitzer, G., Xu, Q., and Wilkinson, D. G. (2000) Control of cell behaviour by signalling through Eph receptors and ephrins. Curr. Opin. Neurobid. 10, 400-408.
41. Boyd, A. W., and Lackmann, M. (2001) Signals from Eph and ephrin proteins: a developmental tool kit. Sci. STKE, 2001, RE20.
42. Cowan, C. A., Yokoyama, N., Saxena, A., Chumley, M. J., Silvany, R. E., Baker, L. A., Srivastava, D., and Henkemeyer, M. (2004) Ephrin-B2 reverse signalling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev. Biol. 271, 263-271.
43. Grunwald, I. C., Korte, M., Wolfer, D., Wilkinson, G. A., Unsicker, K., Lipp, H. P., Bonhoeffer, T., and Klein, R. (2001) Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron 32, 1027-1040.
44. Zimmer, M., Palmer, A., Kohler, J., and Klein, R. (2003) EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nat. Cell Biol. 5, 869-878.
45. Marston, D. J., Dickinson, S., and Nobes, C. D. (2003) Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat. Cell Biol. 5, 879-888.
46. Hattori, M., Osterfield, M., and Flanagan, J. G. (2000) Regulated cleavage of a contact-mediated axon repellent. Science 289, 1360-1365.
47. Holmberg, J., and Frisen, J. (2002) Ephrins are not only unattractive. Trends Neurosci. 25, 239-243.
48. Huynh-Do, U., Stein, E., Lane, A. A., Liu, H., Cerretti, D. P., and Daniel, T. O. (1999) Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J. 18, 2165-2173.
49. Davy, A., and Robbins, S. M. (2000) Ephrin-A5 modulates cell adhesion and morphology in an integrin- dependent manner. EMBO J. 19, 5396-5405.
50. Huynh-Do, U., Vindis, C., Liu, H., Cerretti, D. P., McGrew, J. T., Enriquez, M., Chen, J., and Daniel, T. O. (2002) Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J. Cell Sci. 115, 3073-3081.
51. Miao, H., Burnett, E., Kinch, M., Simon, E., and Wang, B. (2000) Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2, 62-69.
52. Carter, N., Nakamoto, T., Hirai, H., and Hunter, T. (2002) EphrinA 1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat. Cell Biol. 4, 565-573.
53. Bogenrieder, T., and Herlyn, M. (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22, 6524-6536.
54. Friedl, P., and Wolf, K. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374.
55. Noren, N. K., and Pasquale, E. B. (2004) Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal. 16, 655-666.
56. Stein, E., Lane, A. A., Cerretti, D. P., Schoecklmann, H. O., Schroff, A. D., Van Etten, R. L., and Daniel, T. O. (1998) Eph receptors discriminate specific ligand oligomers to determine alternative signalling complexes, attachment, and assembly responses. Genes Dev. 12, 667-678.
57. Lawrenson, I. D., Wimmer-Kleikamp, S. H., Lock, P., Schoenwaelder, S. M., Down, M., Boyd, A. W., Alewood, P. F., and Lackmann, M. (2002) Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3- expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J. Cell Sci. 115, 1059-1072.
58. Gu, C., and Park, S. (2001) The EphAS receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol. Cell Biol. 21, 4579-4597.
59. Zou, J. X., Liu, Y., Pasquale, E. B., and Ruoslahti, E. (2002) Activated SRC oncogene phosphorylates R-ras and suppresses integrin activity. J. Biol. Chem. 277, 1824-1827.
60. Miao, H., Strebhardt, K., Pasquale, E. B., Shen, T. L., Guan, J. L., and Wang, B. (2004) Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase: Role of Rho family small GTPases. J. Biol. Chem. 280, 923-32.
61. Orsulic, S., and Kemler, R. (2000) Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J. Cell Sci. 113, 1793-1802.
62. Hendrix, M. J., Seftor, E. A., Hess, A. R., and Seftor, R. E. (2003) Molecular plasticity of human melanoma cells. Oncogene 22, 3070-3075.
63. Potla, L., Boghaert, E. R., Armellino, D., Frost, P., and Damle, N. K. (2002) Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells. Cancer Lett. 175, 187-195.
64. Shevde, L. A., and Welch, D. R. (2003) Metastasis suppressor pathways - an evolving paradigm. Cancer Lett. 198, 1-20.
65. Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M., and Pasquale, E. B. (2004) Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc. Natl. Acad. Sci. USA 101, 5583-5588.
66. Etienne-Manneville, S., and Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635.
67. Shamah, S. M., Lin, M. Z., Goldberg, J. L., Estrach, S., Sahin, M., Hu, L., Bazalakova, M., Neve, R. L., Corfas, G., Debant, A., and Greenberg, M. E. (2001) EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 105, 233-244.
68. Nagashima, K., Endo, A., Ogita, H., Kawana, A., Yamagishi, A., Kitabatake, A., Matsuda, M., and Mochizuki, N. (2002) Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol. Biol. Cell 13, 4231-4242.
69. Elowe, S., Holland, S. J., Kulkarni, S., and Pawson, T. (2001) Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol. Cell Biol. 21, 7429-7441.
70. Tong, J., Elowe, S., Nash, P., and Pawson, T. (2003) Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signalling and biological activity. J. Biol. Chem. 278, 6111-6119.
71. Holland, S. J., Gale, N. W., Gish, G. D., Roth, R. A., Songyang, Z., Cantley, L. C., Henkemeyer, M., Yancopoulos, G. D., and Pawson, T. (1997) Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 16, 3877-3888.
72. Conover, J. C., Doetsch, F., Garcia-Verdugo, J. M., Gale, N. W., Yancopoulos, G. D., and Alvarez-Buylla, A. (2000) Disruption of Eph/ephrin signalling affects migration and proliferation in the adult subventricular zone. Nat. Neurosci. 3, 1091-1097.
73. Holmberg, J., Armulik, A., Senti, K. A., Edoff, K., Spalding, K., Momma, S., Cassidy, R., Flanagan, J. G., and Frisen, J. (2005) Ephrin-A2 reverse signalling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev. 19, 462-471.
74. Tischer, C. and Bastiens, P. I. (2003) Lateral phosphorylation propagation: an aspect of feedback signalling? Nat. Rev. Mol. Cell Biol. 4, 971-974.
75. Luo, H., Wan, X., Wu, Y., and Wu, J. (2001) Cross-linking of EphB6 resulting in signal transduction and apoptosis in Jurkat cells. J. Immunol. 167, 1362-1370.
76. Kikawa, K. D., Vidale, D. R., Van Etten, R. L., and Kinch, M. S. (2002) Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J. Biol. Chem. 277, 39274-39279.
77. Palmer, A., Zimmer, M., Erdmann, K. S., Eulenburg, V., Porthin, A., Heumann, R., Deutsch, U., and Klein, R. (2002) EphrinB phosphorylation and reverse signalling: regulation by Src kinases and PTP-BL phosphatase. Mol. Cell 9, 725-737.
78. Park, S. (2003) The EphAS receptor phosphorylates and activates low molecular weight phosphotyrosine protein phosphatase in vitro. J. Biochem. Mol. Biol. 36, 288-293.
79. Chiarugi, P., Taddei, M. L., Schiavone, N., Papucci, L., Giannoni, E., Fiaschi, T., Capaccioli, S., Raugei, G., and Ramponi, G. (2004) LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 23, 3905-3914.
80. Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S., Willson, J. K., Parmigiani, G., Kinzler, K. W., Vogelstein, B., and Velculescu, V. E. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949.
81. Cheng, N., Brantley, D., Fang, W. B., Liu, H., Fanslow, W., Cerretti, D. P., Bussell, K. N., Reith, A., Jackson, D., and Chen, J. (2003) Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 5, 445-456.
82. Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., Lin, C., and Chen, J. (2002) Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21, 7011-7026.
83. Martiny-Baron, G., Korff, T., Schaffner, F., Esser, N., Eggstein, S., Marme, D., and Augustin, H. G. (2004) Inhibition of tumor growth and angiogenesis by soluble EphB4. Neoplasia 6, 248-257.
84. Liu, W., Jung, Y. D., Ahmad, S. A., McCarty, M. F., Stoeltzing, O., Reinmuth, N., Fan, F., and Ellis, L. M. (2004) Effects of over-expression of ephrin-B2 on tumour growth in human colorectal cancer. Br. J. Cancer 90, 1620-1626.
85. Mao, W., Luis, E., Ross, S., Silva, J., Tan, C., Crowley, C., Chui, C., Franz, G., Senter, P., Koeppen, H., and Polakis, P. (2004) EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer. Cancer Res. 64, 781-788.
86. Alves, P. M., Faure, O., Graff-Dubois, S., Gross, D. A., Cornet, S., Chouaib, S., Miconnet, I., Lemonnier, F. A., and Kosmatopoulos, K. (2003) EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201- restricted epitopes. Cancer Res. 63, 8476-8480.
87. Berclaz, G., Karamitopoulou, E., Mazzuchelli, L., Rohrbach, V., Dreher, E., Ziemiecki, A., Andres, A. C., (2003) Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma. Ann. Oncol. 14, 220-6.